TD Cowen said in a January note that retatrutide could bring in $3.8 billion in sales by 2030
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrm-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J-P, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL
What to Expect at 6 Months At the six-month mark, most patients have reached their maintenance dose and are beginning to see significant results
Compounded medications do not undergo vigorous testing like FDA-approved drugs
Clinical guidelines, as the post describes them, favor risk stratification with close monitoring over automatic exclusion
Your provider will map this out so you understand the rationale and endpoint rather than feeling locked into indefinite visits